Log in

NASDAQ:TXMDTherapeuticsMD SEC Filings & 10K Form

$1.50
+0.03 (+2.04 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.41
Now: $1.50
$1.53
50-Day Range
$1.12
MA: $1.27
$1.58
52-Week Range
$0.85
Now: $1.50
$4.32
Volume2.66 million shs
Average Volume4.79 million shs
Market Capitalization$407.52 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16

SEC Filings

TherapeuticsMD (NASDAQ:TXMD) SEC Filings

DateFilerForm TypeView
06/23/2020
5:51 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2020
4:11 PM
BISARO PAUL (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:11 PM
TherapeuticsMD (Issuer)
Thompson Tommy G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:10 PM
Russell Angus C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:10 PM
Naughton Gail K (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:09 PM
MUSING JULES A. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:08 PM
Ling Karen (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:08 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:07 PM
CARROLL J MARTIN (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/19/2020
4:07 PM
DArecca James (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2020
3:21 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2020
3:25 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2020
4:51 PM
DArecca James (Reporting)
TherapeuticsMD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
06/01/2020
5:52 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2020
6:07 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2020
4:23 PM
TherapeuticsMD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2020
5:55 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/05/2020
11:15 PM
TherapeuticsMD (Filer)
Form EFFECT
05/04/2020
4:01 PM
TherapeuticsMD (Filer)
Form DEF 14A
04/28/2020
8:48 PM
TherapeuticsMD (Filer)
Form 10-K/A
04/22/2020
4:17 PM
Ling Karen (Reporting)
TherapeuticsMD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/22/2020
4:10 PM
TherapeuticsMD (Filer)
Form PRER14A
04/22/2020
4:02 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/13/2020
4:16 PM
TherapeuticsMD (Filer)
Form PRE 14A
04/01/2020
7:33 PM
Milligan John C.K. IV (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
7:32 PM
Finizio Robert G (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
7:32 PM
Krassan Mitchell (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
7:31 PM
Cartwright Daniel A (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2020
7:30 PM
Donegan Michael C (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/26/2020
8:11 PM
Naughton Gail K (Reporting)
TherapeuticsMD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/26/2020
8:08 PM
BISARO PAUL (Reporting)
TherapeuticsMD (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
03/24/2020
6:53 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2020
6:00 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/24/2020
3:56 PM
TherapeuticsMD (Filer)
Form POS AM
02/20/2020
5:57 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2020
8:10 AM
BlackRock Inc. (Filed by)
TherapeuticsMD (Subject)
Form SC 13G/A
02/05/2020
5:07 PM
Krassan Mitchell (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/21/2020
8:28 AM
JPMORGAN CHASE & CO (Filed by)
TherapeuticsMD (Subject)
Form SC 13G/A
01/14/2020
5:55 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
6:02 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2019
4:27 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2019
1:54 PM
Bank of New York Mellon Corp (Filed by)
TherapeuticsMD (Subject)
Form SC 13G/A
11/19/2019
5:46 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
3:08 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2019
4:03 PM
Milligan John C.K. IV (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
4:01 PM
Milligan John C.K. IV (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
3:56 PM
Bernick Brian (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
3:55 PM
Finizio Robert G (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2019
7:52 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/25/2019
3:47 PM
TherapeuticsMD (Filer)
Form 424B2
10/24/2019
5:02 AM
TherapeuticsMD (Subject)
Form FWP
10/23/2019
4:25 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
4:16 PM
TherapeuticsMD (Subject)
Form FWP
10/23/2019
4:15 PM
TherapeuticsMD (Filer)
Form 424B5
10/15/2019
6:00 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/01/2019
6:01 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2019
5:31 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/16/2019
5:46 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2019
2:27 PM
Bank of New York Mellon Corp (Filed by)
TherapeuticsMD (Subject)
Form SC 13G/A
08/30/2019
8:50 PM
Donegan Michael C (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
8:49 PM
Krassan Mitchell (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
8:49 PM
Milligan John C.K. IV (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
8:48 PM
Bernick Brian (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
8:48 PM
Finizio Robert G (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2019
8:48 PM
Cartwright Daniel A (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2019
4:14 PM
Russell Angus C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2019
4:12 PM
Finizio Robert G (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2019
3:56 PM
Milligan John C.K. IV (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
3:33 PM
Russell Angus C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2019
4:32 PM
Finizio Robert G (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
2:00 PM
TherapeuticsMD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
3:07 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2019
5:57 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2019
6:04 PM
TherapeuticsMD (Issuer)
Thompson Tommy G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:03 PM
SEGAL NICHOLAS (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:03 PM
Russell Angus C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:02 PM
MUSING JULES A. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:02 PM
LaPenta Robert V Jr (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:01 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:01 PM
CARROLL J MARTIN (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2019
6:00 PM
Barlow Jane F (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2019
3:56 PM
TherapeuticsMD (Filer)
Form S-8 POS
06/21/2019
3:45 PM
TherapeuticsMD (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/21/2019
3:22 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2019
1:28 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2019
6:15 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2019
4:03 PM
Collins Cooper C. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:00 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2019
5:00 PM
TherapeuticsMD (Issuer)
Thompson Tommy G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2019
4:02 PM
TherapeuticsMD (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2019
3:07 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2019
8:05 PM
TherapeuticsMD (Filer)
Form DEFA14A
04/25/2019
3:33 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
3:08 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
10:06 AM
TherapeuticsMD (Filer)
Form CT ORDER
04/08/2019
6:00 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
6:00 AM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/01/2019
4:30 PM
MUSING JULES A. (Reporting)
TherapeuticsMD (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:09 PM
TherapeuticsMD (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2019
11:06 AM
FMR LLC (Filed by)
TherapeuticsMD (Subject)
Form SC 13G/A
This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.